{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:16:28Z","timestamp":1790018188448,"version":"4.0.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T00:00:00Z","timestamp":1564358400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T00:00:00Z","timestamp":1564358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Forensic Sci Med Pathol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s12024-019-00144-z","type":"journal-article","created":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T09:02:48Z","timestamp":1564390968000},"page":"616-621","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Immunodeficiency as a side effect of anabolic androgenic steroid abuse: a case of necrotizing myofasciitis"],"prefix":"10.1007","volume":"15","author":[{"given":"Giuseppe","family":"Bertozzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0357-8791","authenticated-orcid":false,"given":"Francesco","family":"Sessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Maglietta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Cipolloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Salerno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palmira","family":"Fortarezza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietrantonio","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Turillazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristoforo","family":"Pomara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,29]]},"reference":[{"key":"144_CR1","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11154-015-9320-5","volume":"16","author":"E Nieschlag","year":"2015","unstructured":"Nieschlag E, Vorona E. Doping with anabolic androgenic steroids (AAS): adverse effects on non-reproductive organs and functions. Rev Endocr Metab Disord. 2015;16:199\u2013211.","journal-title":"Rev Endocr Metab Disord"},{"key":"144_CR2","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2174\/1570159X13666141210222725","volume":"13","author":"D Piacentino","year":"2015","unstructured":"Piacentino D, Kotzalidis GD, del Casale A, Aromatario MR, Pomara C, Girardi P, et al. Anabolic-androgenic steroid use and psychopathology in athletes. A systematic review. Curr Neuropharmacol. 2015;13:101\u201321.","journal-title":"Curr Neuropharmacol"},{"key":"144_CR3","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2174\/1570159X13666141210225414","volume":"13","author":"P Frati","year":"2015","unstructured":"Frati P, Busard\u00f2 FP, Cipolloni L, De Dominicis E, Fineschi V. Anabolic androgenic steroid (AAS) related deaths: Autoptic, histopathological and toxicological findings. Curr Neuropharmacol. 2015;13:146\u201359.","journal-title":"Curr Neuropharmacol"},{"key":"144_CR4","first-page":"939","volume":"2017","author":"GD Albano","year":"2017","unstructured":"Albano GD, Sessa F, Messina A, Monda V, Bertozzi G, Maglietta F, et al. AAS and organs damage: a focus on Nandrolone effects. Acta Medica Mediterr. 2017;2017:939\u201346.","journal-title":"Acta Medica Mediterr"},{"key":"144_CR5","unstructured":"World Anti-Doping Agency. The 2019 list of prohibited substances and methods. 2019. \nhttps:\/\/www.wada-ama.org\/sites\/default\/files\/wada_2019_english_prohibited_list.pdf"},{"key":"144_CR6","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.annepidem.2014.01.009","volume":"24","author":"D Sagoe","year":"2014","unstructured":"Sagoe D, Molde H, Andreassen CS, Torsheim T, Pallesen S. The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis. Ann Epidemiol. 2014;24:383\u201398.","journal-title":"Ann Epidemiol"},{"key":"144_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13011-016-0056-3","volume":"11","author":"A B\u00f6rjesson","year":"2016","unstructured":"B\u00f6rjesson A, G\u00e5revik N, Dahl ML, Rane A, Ekstr\u00f6m L. Recruitment to doping and help-seeking behavior of eight female AAS users. Subst Abus Treat Prev Policy. 2016;11:11.","journal-title":"Subst Abus Treat Prev Policy."},{"key":"144_CR8","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/JSM.0b013e3181fb5370","volume":"20","author":"EJ Ip","year":"2010","unstructured":"Ip EJ, Barnett MJ, Tenerowicz MJ, Kim JA, Wei H, Perry PJ. Women and anabolic steroids: an analysis of a dozen users. Clin J Sport Med. 2010;20:475\u201381.","journal-title":"Clin J Sport Med"},{"issue":"Special Is","key":"144_CR9","first-page":"2135","volume":"34","author":"F Sessa","year":"2018","unstructured":"Sessa F, Franco S, Picciocchi E, Geraci D, Chisari MG, Marsala G, et al. Forensic considerations on violent parasomnias during lifespan. Acta Medica Mediterr. 2018;34(Special Is):2135\u201342.","journal-title":"Acta Medica Mediterr"},{"key":"144_CR10","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1080\/14659891.2016.1179806","volume":"22","author":"O Abrahin","year":"2017","unstructured":"Abrahin O, F\u00e9lix Souza NS, de Sousa EC, Santos AM, Bahrke MS. Anabolic\u2013androgenic steroid use among Brazilian women: an exploratory investigation. J Subst Use. 2017;22:246\u201352.","journal-title":"J Subst Use"},{"key":"144_CR11","doi-asserted-by":"publisher","first-page":"19415","DOI":"10.18632\/oncotarget.24767","volume":"9","author":"M Salerno","year":"2018","unstructured":"Salerno M, Cascio O, Bertozzi G, Sessa F, Messina A, Monda V, et al. Anabolic androgenic steroids and carcinogenicity focusing on Leydig cell: a literature review. Oncotarget. 2018;9:19415\u201326.","journal-title":"Oncotarget."},{"key":"144_CR12","doi-asserted-by":"publisher","first-page":"5548","DOI":"10.1007\/s12035-017-0774-1","volume":"55","author":"G Bertozzi","year":"2018","unstructured":"Bertozzi G, Sessa F, Albano GD, Sani G, Maglietta F, Roshan MHK, et al. The role of anabolic androgenic steroids in disruption of the physiological function in discrete areas of the central nervous system. Mol Neurobiol. 2018;55:5548\u201356.","journal-title":"Mol Neurobiol"},{"key":"144_CR13","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1002\/jcp.25272","volume":"231","author":"C Pomara","year":"2016","unstructured":"Pomara C, Barone R, Marino Gammazza A, Sangiorgi C, Barone F, Pitruzzella A, et al. Effects of nandrolone stimulation on testosterone biosynthesis in Leydig cells. J Cell Physiol. 2016;231:1385\u201391.","journal-title":"J Cell Physiol"},{"key":"144_CR14","doi-asserted-by":"publisher","first-page":"166","DOI":"10.18632\/aging.101386","volume":"10","author":"F Sessa","year":"2018","unstructured":"Sessa F, Anna V, Messina G, Cibelli G, Monda V, Marsala G, et al. Heart rate variability as predictive factor for sudden cardiac death. Aging. 2018;10:166\u201377.","journal-title":"Aging."},{"key":"144_CR15","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1089\/gtmb.2010.0179","volume":"15","author":"F Sessa","year":"2011","unstructured":"Sessa F, Chetta M, Petito A, Franzetti M, Bafunno V, Pisanelli D, et al. Gene polymorphisms and sport attitude in Italian athletes. Genet Test Mol Biomarkers. 2011;15:285\u201390.","journal-title":"Genet Test Mol Biomarkers"},{"key":"144_CR16","doi-asserted-by":"publisher","first-page":"16015","DOI":"10.1038\/ncomms16015","volume":"8","author":"SM Willems","year":"2017","unstructured":"Willems SM, Wright DJ, Day FR, Trajanoska K, Joshi PK, Morris JA, et al. Large-scale GWAS identifies multiple loci for hand grip strength providing biological insights into muscular fitness. Nat Commun. 2017;8:16015.","journal-title":"Nat Commun"},{"key":"144_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0156601","volume":"11","author":"A Petito","year":"2016","unstructured":"Petito A, Altamura M, Iuso S, Padalino FA, Sessa F, D\u2019Andrea G, et al. The relationship between personality traits, the 5HTT polymorphisms, and the occurrence of anxiety and depressive symptoms in elite athletes. PLoS One. 2016;11:e0156601.","journal-title":"PLoS One"},{"key":"144_CR18","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1249\/01.mss.0000210194.56834.5d","volume":"38","author":"AB Parkinson","year":"2006","unstructured":"Parkinson AB, Evans NA. Anabolic androgenic steroids: a survey of 500 users. Med Sci Sports Exerc. 2006;38:644\u201351.","journal-title":"Med Sci Sports Exerc"},{"key":"144_CR19","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1177\/1477370816633261","volume":"13","author":"GA Antonopoulos","year":"2016","unstructured":"Antonopoulos GA, Hall A. \u2018Gain with no pain\u2019: anabolic-androgenic steroids trafficking in the UK. Eur J Criminol. 2016;13:696\u2013713.","journal-title":"Eur J Criminol"},{"key":"144_CR20","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1016\/j.forsciint.2013.02.035","volume":"228","author":"DB da Justa Neves","year":"2013","unstructured":"da Justa Neves DB, Marcheti RGA, Caldas ED. Incidence of anabolic steroid counterfeiting in Brazil. Forensic Sci Int. 2013;228:e81\u20133.","journal-title":"Forensic Sci Int"},{"key":"144_CR21","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00228-014-1743-5","volume":"70","author":"O Krug","year":"2014","unstructured":"Krug O, Thomas A, Walpurgis K, Piper T, Sigmund G, Sch\u00e4nzer W, et al. Identification of black market products and potential doping agents in Germany 2010-2013. Eur J Clin Pharmacol. 2014;70:1303\u201311.","journal-title":"Eur J Clin Pharmacol"},{"key":"144_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugpo.2017.01.016","volume":"40","author":"C Chatwin","year":"2017","unstructured":"Chatwin C, Measham F, O\u2019Brien K, Sumnall H. New drugs, new directions? Research priorities for new psychoactive substances and human enhancement drugs. Int J Drug Policy. 2017;40:1\u20135.","journal-title":"Int J Drug Policy"},{"key":"144_CR23","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s11332-018-0464-z","volume":"3","author":"F Sessa","year":"2018","unstructured":"Sessa F, Messina G, Valenzano A, Messina A, Salerno M, Marsala G, et al. Sports training and adaptive changes. Sport Sci Health. 2018;3:705\u20138.","journal-title":"Sport Sci Health"},{"key":"144_CR24","doi-asserted-by":"publisher","first-page":"R47","DOI":"10.1530\/EJE-15-0080","volume":"173","author":"E Nieschlag","year":"2015","unstructured":"Nieschlag E, Vorona E. Mechanisms in endocrinology: medical consequences of doping with anabolic androgenic steroids: effects on reproductive functions. Eur J Endocrinol. 2015;173:R47\u201358.","journal-title":"Eur J Endocrinol"},{"key":"144_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13011-015-0006-5","volume":"10","author":"D Sagoe","year":"2015","unstructured":"Sagoe D, McVeigh J, Bj\u00f8rnebekk A, Essilfie MS, Andreassen CS, Pallesen S. Polypharmacy among anabolic-androgenic steroid users: a descriptive metasynthesis. Subst Abus Treat Prev Policy. 2015;10:12.","journal-title":"Subst Abus Treat Prev Policy"},{"key":"144_CR26","first-page":"981","volume":"55","author":"R Puvanendran","year":"2009","unstructured":"Puvanendran R, Huey JCM, Pasupathy S. Necrotizing fasciitis. Can Fam Physician. 2009;55:981\u20137.","journal-title":"Can Fam Physician"},{"key":"144_CR27","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.2106\/00004623-200308000-00005","volume":"85","author":"CH Wong","year":"2003","unstructured":"Wong CH, Chang HC, Pasupathy S, Khin LW, Tan JL, Low CO. Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Jt Surg - Ser A. 2003;85:1454\u201360.","journal-title":"J Bone Jt Surg - Ser A"},{"key":"144_CR28","doi-asserted-by":"publisher","first-page":"e823","DOI":"10.1016\/j.ijid.2010.05.012","volume":"14","author":"S Grant","year":"2010","unstructured":"Grant S, Dearing J, Ghosh S, Collier A, Bal AM. Necrotizing myositis of the deltoid following intramuscular injection of anabolic steroid. Int J Infect Dis. 2010;14:e823\u20134.","journal-title":"Int J Infect Dis"},{"key":"144_CR29","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s00296-009-1235-6","volume":"31","author":"M Hughes","year":"2011","unstructured":"Hughes M, Ahmed S. Anabolic androgenic steroid induced necrotising myopathy. Rheumatol Int. 2011;31:915\u20137.","journal-title":"Rheumatol Int"},{"key":"144_CR30","first-page":"97","volume":"46","author":"N Souza","year":"2011","unstructured":"Souza N, Filho C, Figueirido Gaspar E, Siqueira KL, Monteiro GC, Andreoli CV, et al. Pyomyositis in athletes after use of anabolic steroids - case reports. Soc Bras Ortop e Traumatol. 2011;46:97\u2013100.","journal-title":"Soc Bras Ortop e Traumatol"},{"key":"144_CR31","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1517\/14740338.2015.1094052","volume":"14","author":"SM Choi","year":"2015","unstructured":"Choi SM, Lee B-M. Comparative safety evaluation of selective androgen receptor modulators and anabolic androgenic steroids. Expert Opin Drug Saf. 2015;14:1773\u201385.","journal-title":"Expert Opin Drug Saf"},{"key":"144_CR32","doi-asserted-by":"publisher","first-page":"438","DOI":"10.2174\/138955711795445907","volume":"11","author":"EW Brenu","year":"2011","unstructured":"Brenu EW, McNaughton L, Marshall-Gradisnik SM. Is there a potential immune dysfunction with anabolic androgenic steroid use?: a review. Mini-Reviews Med Chem. 2011;11:438\u201345.","journal-title":"Mini-Reviews Med Chem"},{"key":"144_CR33","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/0192-0561(95)00078-X","volume":"17","author":"TK Hughes","year":"1995","unstructured":"Hughes TK, Fulep E, Juelich T, Smith EM, Stanton GJ. Modulation of immune responses by anabolic androgenic steroids. Int J Immunopharmacol. 1995;17:857\u201363.","journal-title":"Int J Immunopharmacol"},{"issue":"2 Suppl 2","key":"144_CR34","first-page":"S195","volume":"125","author":"J Chinen","year":"2009","unstructured":"Chinen J, Shearer WT. Secondary immunodeficiencies, including HIV infection. J Allergy Clin Immunol. 2009;125(2 Suppl 2):S195\u2013203.","journal-title":"J Allergy Clin Immunol"},{"key":"144_CR35","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.2165\/00003495-200666120-00001","volume":"66","author":"HP Tan","year":"2006","unstructured":"Tan HP, Smaldone MC, Shapiro R. Immunosuppressive preconditioning or induction regimens: evidence to date. Drugs. 2006;66:1535\u201345.","journal-title":"Drugs."},{"key":"144_CR36","doi-asserted-by":"crossref","first-page":"495863","DOI":"10.1155\/2009\/495863","volume":"2009","author":"DM Mintzer","year":"2009","unstructured":"Mintzer DM, Billet SN, Chmielewski L. Drug-induced hematologic syndromes. Adv Hematol. 2009;2009:495863.","journal-title":"Adv Hematol"},{"key":"144_CR37","doi-asserted-by":"crossref","unstructured":"Sessa F, Salerno M, Di Mizio G, Bertozzi G, Messina G, Tomaiuolo B, et al. Anabolic androgenic steroids: searching new molecular biomarkers. Front Pharmacol. 2018;91321.","DOI":"10.3389\/fphar.2018.01321"},{"key":"144_CR38","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1111\/j.1365-2516.2012.02882.x","volume":"18","author":"V Bafunno","year":"2012","unstructured":"Bafunno V, Santacroce R, Chetta M, Peyvandi F, Sessa F, Chinni E, et al. Polymorphic miRNA-mediated gene contribution to inhibitor development in haemophilia A. Haemophilia. 2012;18:1003\u20137.","journal-title":"Haemophilia."}],"container-title":["Forensic Science, Medicine and Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12024-019-00144-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12024-019-00144-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12024-019-00144-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T23:47:01Z","timestamp":1595893621000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12024-019-00144-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,29]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["144"],"URL":"https:\/\/doi.org\/10.1007\/s12024-019-00144-z","relation":{},"ISSN":["1547-769X","1556-2891"],"issn-type":[{"value":"1547-769X","type":"print"},{"value":"1556-2891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,29]]},"assertion":[{"value":"5 July 2019","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors hereby declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in the study were in accordance with the ethical standards of the institution and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from the relatives.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"The authors declare to have received written consent from relatives of all persons involved in this case report, to publish the article mentioned above in the Journal of Forensic Science, Medicine, and Pathology.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}